|1.||Ilbäck, Nils-Gunnar: 2 articles (07/2004 - 02/2002)|
|2.||Rana, Suresh Vir Singh: 1 article (01/2008)|
|3.||Lindh, Ulf: 1 article (07/2004)|
|4.||Netzel, Elvy: 1 article (07/2004)|
|5.||Wikberg, Lotta: 1 article (07/2004)|
|6.||Glynn, Anders W: 1 article (07/2004)|
|7.||Eloranta, Maija-Leena: 1 article (02/2002)|
|8.||Friman, Göran: 1 article (02/2002)|
|9.||Funseth, Eva: 1 article (02/2002)|
|10.||Påhlman, Martin: 1 article (02/2002)|
07/01/2004 - "CB3 adapted to Balb/c mice was used to study whether infection affects the Cd-binding protein, metallothionein (MT) and if this alters the normal physiological trace element balance in the liver, kidney, spleen and brain. "
02/04/2002 - "To study if CB3 infection affects the synthesis of the Cd-binding protein metallothionein (MT) and the TCDD-binding/detoxifying cytochrome P-450 (CYP-450) isozyme CYP1A1, the basal and TCDD-induced levels of serum MT and liver CYP1A1 isozyme were determined in healthy and CB3-infected A/J mice. "
09/01/1987 - "Cadmium-metallothionein nephrotoxicity in the rat: transient calcuria and proteinuria."
04/18/1994 - "Cadmium metallothionein (CdMT) was injected subcutaneously into obese hyperglycaemic Umeå ob/ob mice or their lean litter mates (normal mice) at doses of 0, 0.1 and 0.4 mg Cd/kg. Proteinuria and calciuria were induced in both types of mice, but in the ob/ob mice this condition developed at a lower dose of CdMT (0.1 mg Cd/kg) than in the normal mice (0.4 mg Cd/kg). "
10/01/1983 - "Ultrastructural morphometry, X-ray microanalysis, and biochemical studies of the low-molecular-weight tubular proteinuria produced by injection of cadmium metallothionein (CdMT) showed a rapid proximal tubule cell lysosome uptake and degradation of the CdMT complex, which led to a subsequent decrease in the numerical density (Nv) and average diameter of lysosomes and to an increase in the Nv of apical pinocytolic vesicles with time. "
|3.||Cadmium Poisoning (Itai Itai)
04/01/1980 - "The author described here recent progress and perspectives on cadmium health effect studies, cadmium analysis in biological samples; absorption, distribution and excretion of cadmium; health effects of residents in cadmium-polluted area; survey on the health status of Itai-Itai disease patients; beta 2-microglobulinuria; intestinal tract impairment and bone metabolism; effects on bone; effects on the liver; early diagnosis of cadmium effects; effects on future generations; carcinogenicity; critical concentration of cadmium; metallothionein; recommendations for future studies. "
01/01/1981 - "Metallothionein, a low molecular weight cadmium-binding protein, has been determined for the first time in urine of "itai-itai" disease patients and other Japanese women environmentally exposed to cadmium. "
|4.||Hepatocellular Carcinoma (Hepatoma)
11/01/1992 - "This study compared the uptake and toxicity in vitro of CdCl(2) and two isoforms of rat cadmium-metallothionein (CdMt-1 and CdMt-2) using primary rat kidney cortex cells, primary rat hepatocytes, liver hepatoma cell line H-35, kidney epithelial cell line NRK52-E and intestinal epithelial cell line IEC-18. "
08/01/1978 - "Induction of cadmium-thionein in mouse tumor cells."
04/15/1990 - "Differential pulse polarography was used to monitor the titration of crab (Cancer pagurus) cadmium metallothionein with additional cadmium. "
03/01/1986 - "Occurrence of cadmium in crabs (Cancer pagurus) and the isolation and properties of cadmium metallothionein."
01/01/1997 - "The survival times of tumor-bearing mice were prolonged by administration of cadmium chloride, which induces the synthesis of a combined zinc-cadmium metallothionein derivative in the host liver, but not in the tumor tissue, leading to an increase of hepatic zinc in the treated animals. "
05/01/1995 - "Cadmium, given at a dose known to induce tumors of the ventral prostate (2.5 mumol/kg, sc), did not result in an increase in MT gene expression in the ventral prostate, as assessed by cadmium-binding protein levels or MT-I mRNA, over 72 hr. Small elevations of cadmium-binding protein capacity were detected at high doses of cadmium (25 and 40 mumol/kg) in the ventral prostate but no corresponding increases in MT mRNA were seen. "
|3.||D-4-chloro-17 beta-hydroxy-3-oxo-17 alpha-methylandrosta-1,4-diene
|4.||Protein Isoforms (Isoforms)
|5.||Cytochrome P-450 CYP1A1 (CYP1A1)
|7.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|10.||Cadmium Chloride (Cadmium Dichloride)